Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed.

Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans.

With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization.

Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.

Biotechnology

Health Care

Concert Genetics

Rob Metcalf

Sara Goldstein

Marshall McQuillen

Karen Miller

Beau Bristow

Shelby Powell

Gina Nuccio

Jenna McLosky

Nicole Magdziarz

David Prior

Nick Tazik

Blake Blackshear

Dan Kauke

Gillian Hooker

Chris Dowdy

Leadership Team

Clinical and Data Analytics Team

Engineering Team

Operations Management

��

Teams at Concert Genetics

Leadership Team

Clinical and Data Analytics Team

Engineering Team

Operations Management

��������

Teams at Concert Genetics

Leadership Team

Clinical and Data Analytics Team

Engineering Team

Operations Management

��